Except … tens of millions of us do not hesitate to take longevity drugs every day. These include statins, antihypertensives, etc.
My issue is with “longevity drugs” which have marginal in vitro evidence of efficacy and which rely on biomarkers rather than evidence of actual in vivo benefit. And which may have profound harm. Mind you, I have some questions regarding drugs such as statins when number needed to treat versus number needed to harm data is considered.
Do people do this with the goal and expectation of living indefinitely? Or of, hopefully, improving their health a little or warding off disease and dysfunction?
The status quo bias will crumble when we have available clearly effective longevity therapeutics. In the meantime, it remains in strong effect.
The status quo bias helps to explain why such a tiny fraction of the population has made biostasis arrangements 60 years after it started.
I expect most folks taking these drugs hope to have their life extended, and as high a quality, as possible without regard for how long that may actually be. They certainly do reject the status quo in deciding to take medication to reduce health risks.
Except … tens of millions of us do not hesitate to take longevity drugs every day. These include statins, antihypertensives, etc.
My issue is with “longevity drugs” which have marginal in vitro evidence of efficacy and which rely on biomarkers rather than evidence of actual in vivo benefit. And which may have profound harm. Mind you, I have some questions regarding drugs such as statins when number needed to treat versus number needed to harm data is considered.
Do people do this with the goal and expectation of living indefinitely? Or of, hopefully, improving their health a little or warding off disease and dysfunction?
The status quo bias will crumble when we have available clearly effective longevity therapeutics. In the meantime, it remains in strong effect.
The status quo bias helps to explain why such a tiny fraction of the population has made biostasis arrangements 60 years after it started.
I expect most folks taking these drugs hope to have their life extended, and as high a quality, as possible without regard for how long that may actually be. They certainly do reject the status quo in deciding to take medication to reduce health risks.
It seems to me that taking drugs to reduce health risks is completely status quo. Perhaps I misunderstand you?